Bayer today announced that one late-breaking presentation along with five posters across its cardiovascular programs will be featured at the Heart Failure Society of America (HFSA) Annual Scientific ...
Late-breaking oral presentation will highlight initial clinical results evaluating azer-cel, an allogeneic “off-the-shelf” CD19-directed CAR T-cell therapy, in patients with progressive multiple ...
Additional poster presentations highlight Vafseo® (vadadustat) clinical and economic dataWALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the ...
Eli Lilly and Company (NYSE: LLY) will present new data across its dermatology portfolio at the 2026 Fall Clinical Dermatology ...
Background Heart failure (HF) remains associated with high mortality worldwide despite advances in guideline-directed therapy ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and ...
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 ...
Cardiovascular disease remains the leading cause of death across European Society of Cardiology (ESC) member countries. Yet ...
New long-term data will further substantiate potential of gefurulimab as once-weekly subcutaneous self-administered treatment for adults with gMG Additional data will showcase commitment to advancing ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The global AI race is creating a stark divide in data center reception. While countries like ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Deriving covid misreporting. Notes: The left panel shows periodical (weekly or monthly) mortality and expected mortality from 2015 to 2021 in solid lines, and reported Covid mortality in dashed lines.